Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Brain and Behavior Wiley

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients

Download PDF
8 pages

Loading next page...
 
/lp/wiley/liver-injury-after-pulsed-methylprednisolone-therapy-in-multiple-udKJsrpUAX
Publisher
Wiley
Copyright
© 2018 Published by Wiley Periodicals, Inc.
ISSN
2162-3279
eISSN
2162-3279
DOI
10.1002/brb3.968
Publisher site
See Article on Publisher Site

Abstract

Journal

Brain and Behavior – Wiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

  • Effect of high‐dose intravenous methyl‐prednisolone treatment on intraocular pressure in multiple sclerosis patients with relapse
    Acar, M.; Gedizlioglu, M.; Koskderelioglu, A.; Ozturk, F.; Kilinc, S.; Talay, N.
  • International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
    Alvarez, F.; Berg, P. A.; Bianchi, F. B.; Bianchi, L.; Burroughs, A. K.; Cancado, E. L.; MacSween, R. N.
  • Treatment of acute relapses in multiple sclerosis
    Berkovich, R.
  • Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity
    Carrier, P.; Godet, B.; Crepin, S.; Magy, L.; Debette‐Gratien, M.; Pillegand, B.; Loustaud‐Ratti, V.
  • Methylprednisolone‐induced hepatotoxicity: Experiences from global adverse drug reaction surveillance
    Caster, O.; Conforti, A.; Viola, E.; Edwards, I. R.
  • ACG Clinical Guideline: The diagnosis and management of idiosyncratic drug‐induced liver injury
    Chalasani, N. P.; Hayashi, P. H.; Bonkovsky, H. L.; Navarro, V. J.; Lee, W. M.; Fontana, R. J.
  • Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
    Citterio, A.; La Mantia, L.; Ciucci, G.; Brusaferri, F.; Sibley, W. A.; Midgard, R.; Candelise, L.
  • High‐dose methylprednisolone‐induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature
    D'Agnolo, H. M.; Drenth, J. P.
  • Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis
    Das, D.; Graham, I.; Rose, J.
  • Methylprednisolone‐induced liver injury: Case report and literature review
    Davidov, Y.; Har‐Noy, O.; Pappo, O.; Achiron, A.; Dolev, M.; Ben‐Ari, Z.
  • Drug‐Induced liver injury network features of autoimmune hepatitis in patients with drug‐induced liver injury
    De Boer, Y. S.; Kosinski, A. S.; Urban, T. J.; Zhao, Z.; Long, N.; Chalasani, N.; Hoofnagle, J. H.
  • Acute severe steatohepatitis related to prednisolone therapy
    Dourakis, S. P.; Sevastianos, V. A.; Kaliopi, P.
  • Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey
    Dumortier, J.; Cottin, J.; Lavie, C.; Guillaud, O.; Hervieu, V.; Chambon‐Augoyard, C.; Vial, T.
  • Liver dysfunction associated with intravenous methylprednisolone pulse therapy in patients with Graves’ orbitopathy
    Eguchi, H.; Tani, J.; Hirao, S.; Tsuruta, M.; Tokubuchi, I.; Yamada, K.; Hiromatsu, Y.
  • Corticosteroid‐induced adverse events in adults: Frequency, screening and prevention
    Fardet, L.; Kassar, A.; Cabane, J.; Flahault, A.
  • Methylprednisolone‐induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses
    Ferraro, D.; Mirante, V. G.; Losi, L.; Villa, E.; Simone, A. M.; Vitetta, F.; Sola, P.
  • Recurrent high‐dose intravenous methylprednisolone succinate pulse therapy‐induced hepatopathy in a patient with multiple sclerosis
    Furutama, D.; Kimura, F.; Shinoda, K.; Maeda, T.; Tanaka, T.; Ohsawa, N.
  • Corticosteroids for treating optic neuritis
    Gal, R. L.; Vedula, S. S.; Beck, R.
  • Relapse in multiple sclerosis
    Galea, I.; Ward‐Abel, N.; Heesen, C.
  • Acute hepatitis caused by Solupred in a patient with Crohn disease
    Gerolami, R.; Mambrini, P.; Barthet, M.; Jean‐Pastor, M. J.; Salducci, J.; Grimaud, J. C.
  • Incomplete septal cirrhosis after high‐dose methylprednisolone therapy and regression of liver injury
    Grilli, E.; Galati, V.; Petrosillo, N.; Del Nonno, F.; Baiocchini, A.
  • Liver injury induced by high‐dose methylprednisolone therapy: A case report and brief review of the literature
    Gutkowski, K.; Chwist, A.; Hartleb, M.
  • Clinical features, diagnosis, and natural history of drug‐induced liver injury
    Hayashi, P. H.; Fontana, R. J.
  • Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
    Hidalgo de la Cruz, M.; Miranda Acuña, J. A.; Lozano Ros, A.; Vega Catalina, M.; Salinero Paniagua, E.; Clemente Ricote, G.; Martínez Ginés, M. L.
  • Acute hepatitis related to prednisolone
    Hofstee, H. M.; Nanayakkara, P. W.; Stehouwer, C. D.
  • Multiple sclerosis: Current knowledge and future outlook
    Kamm, C. P.; Uitdehaag, B. M.; Polman, C. H.
  • Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone
    Lal, R.; Bell, S.; Challenger, R.; Hammock, V.; Nyberg, M.; Decker, D.; Young, D.
  • Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
    Lienert, C.; Schawalder, G.; Findling, O.; Kamm, C. P.; Humpert, S.; Mugglin, A.; Mattle, H. P.
  • Hepatotoxicity after high‐dose methylprednisolone for demyelinating disease
    Loraschi, A.; Banfi, P.; Mauri, M.; Sessa, F.; Bono, G.; Cosentino, M.
  • Effect of relapses on development of residual deficit in multiple sclerosis
    Lublin, F. D.; Baier, M.; Cutter, G.
  • Bolus de méthylprednisolone révélant une hépatite auto‐immune chez une patiente atteinte de sclérose en plaques
    Maàmouri, N.; Ketari, S.; Ben Hariz, F.; Belkahla, N.; Romdhane, S. B.; Chouaib, S.; Mami, N. B.
  • Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves’ ophthalmopathy
    Marinó, M.; Morabito, E.; Brunetto, M. R.; Bartalena, L.; Pinchera, A.; Marocci, C.
  • Methylprednisolone‐induced liver injury: A diagnostic challenge
    Melamud, B.; Lurie, Y.; Goldin, E.; Levi, I.; Esayag, Y.
  • Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy
    Moleti, M.; Giuffrida, G.; Sturniolo, G.; Squadrito, G.; Campennì, A.; Morelli, S.; Marinò, M.
  • Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis
    Nanki, T.; Koike, R.; Miyasaka, N.
  • A method for estimating the probability of adverse drug reactions
    Naranjo, C. A.; Busto, U.; Sellers, E. M.; Sandor, P.; Ruiz, I.; Roberts, E. A.; Greenblatt, D. J.
  • Drug‐related hepatotoxicity
    Navarro, V. J.; Senior, J. R.
  • Induced liver injury after high‐dose methylprednisolone in a patient with multiple sclerosis
    Oliveira, A. T.; Lopes, S.; Cipriano, M. A.; Sofia, C.
  • Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
    Polman, C. H.; Reingold, S. C.; Banwell, B.; Clanet, M.; Cohen, J. A.; Filippi, M.; Wolinsky, J. S.
  • Autoimmune hepatitis after high‐dose intravenous methylprednisolone pulse in RR‐MS
    Reuβ, R.; Retzlaff, K.; Vogel, S.; Franke, F. E.; Oschmann, P.
  • Recurrent acute liver toxicity from intravenous methylprednisolone
    Rivero Fernández, M.; Riesco, J. M.; Moreira, V. F.; Moreno, A.; López San Román, A.; Arranz, G.; Ruiz Del Arbol, L.
  • Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid‐associated ophthalmopathy in a patient with Hashimoto's thyroiditis: Case report
    Salvi, M.; Vannucchi, G.; Sbrozzi, F.; Del Castello, A. B.; Carnevali, A.; Fargion, S.; Beck‐Peccoz, P.
  • Mechanisms involved in the side effects of glucocorticoids
    Schäcke, H.; Döcke, W. D.; Asadullah, K.
  • EFNS guideline on treatment of multiple sclerosis relapses: Report of an EFNS task force on treatment of multiple sclerosis relapses
    Sellebjerg, F.; Barnes, D.; Filippini, G.; Midgard, R.; Montalban, X.; Rieckmann, P.; Sørensen, P. S.
  • Short‐term safety of pulse steroid therapy in multiple sclerosis relapses
    Shaygannejad, V.; Ashtari, F.; Alinaghian, M.; Norouzi, R.; Salari, M.; Fatehi, F.
  • Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report
    Takahashi, A.; Kanno, Y.; Takahashi, Y.; Sakamoto, N.; Monoe, K.; Saito, H.; Ohira, H.
  • Methylprednisolone‐induced toxic hepatitis
    Topal, F.; Özaslan, E.; Akbulut, S.; Küçükazman, M.; Yüksel, O.; Altıparmak, E.
  • Fatal liver failure after high‐dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease
    Weissel, M.; Hauff, W.